Altarac David 4

4 · Entasis Therapeutics Holdings Inc. · Filed Nov 3, 2021

Insider Transaction Report

Form 4
Period: 2021-11-02
Altarac David
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2021-11-02$2.94/sh3,669$10,78742,572 total
Footnotes (1)
  • [F1]Represents shares withheld solely for purposes of the payment of taxes arising in connection with the vesting of restricted stock units on November 2, 2021. The number of shares withheld was determined based on the closing price on the last trading day prior to vesting, which was November 1, 2021.

Documents

1 file
  • 4
    tm2131811-6_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT